elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q24234273-D1C62A64-CB02-4A1D-A4A9-F49699BA3903
Q24234273-D1C62A64-CB02-4A1D-A4A9-F49699BA3903
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24234273-D1C62A64-CB02-4A1D-A4A9-F49699BA3903
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications
P2860
Q24234273-D1C62A64-CB02-4A1D-A4A9-F49699BA3903
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24234273-D1C62A64-CB02-4A1D-A4A9-F49699BA3903
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a86ce48ac91d12724044ba0b89bcb5534f44771b
P2860
The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's disease